Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Patients with Alzheimer disease and cognitive impairment with delayed REM sleep patterns have increased levels of brain amyloid and tau.

A new study highlights how Alzheimer’s disease-associated proteins differentially affect tissues in a whole organism.

Using whole-cell patch-clamp recordings in live anesthetized mice, the researchers found that bursting again was way down in tau mice. Compared to their wild-type counterparts, roughly 80 percent of ...

New research reveals that blood markers linked to Alzheimer’s disease signal a faster decline in muscle strength among older ...

Muscimol, a GABA-A (GABAA) receptor agonist, enhances GABA's inhibitory effect on neuronal activity by activating GABAA ...

Research conducted at Uskudar University (Istanbul, Turkey) explored the neuroprotective potential of ethanolic extracts of ...

Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...

Researchers used the US Mortality Database to assess the relationship between hypothyroidism and Alzheimer disease mortality.

In this article, we first discuss the evidence indicating that inhibition of tau hyperphosphorylation is a viable therapeutic strategy for AD and other tauopathies, and then summarize progress in ...

After a rocky start to the spring, Wall Street came roaring back in May. President Trump’s softened tariff stance reignited ...

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto ...